塩基編集市場：製品別（プラットフォーム、試薬＆キット、プラスミド）、サービス別（gRNA設計、細胞株工学）、タイプ別、標的塩基別（シトシン、アデニン）、用途別（創薬、農業、獣医学）、地域別 - 2028年までの世界予測

Base Editing Market by Product (Platform, Reagents & Kits, Plasmids), Service (gRNA Design, Cell Line Engineering), Type, Targeted base (Cytosine, Adenine), Application (Drug Discovery, Agriculture, Veterinary), and Region - Global Forecast to 2028

塩基編集市場は、2023年の推定2億7,000万米ドルから2028年には5億4,900万米ドルに達すると予測され、予測期間中の年平均成長率は15.2％である。この市場の成長は、新規遺伝子治療と個別化医療に対する需要の高ま... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2023年12月14日	US$4,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	265	352	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

塩基編集市場は、2023年の推定2億7,000万米ドルから2028年には5億4,900万米ドルに達すると予測され、予測期間中の年平均成長率は15.2％である。この市場の成長は、新規遺伝子治療と個別化医療に対する需要の高まりと、新たに操作された分子の開発に起因している。その結果、希少な遺伝性疾患の治療や遺伝子組み換え作物の収穫量の増加が期待され、市場全体の成長を後押ししている。様々な疾患における遺伝子変異の役割に対する認識の高まりが、精密な遺伝子編集技術に対する需要を煽っている。疾患の原因となる変異を修正する塩基編集の能力は、遺伝性疾患への対処におけるその関連性に寄与している。

"2022年、プラットフォームセグメントが製品・サービス別で最大シェアを占める"
2022年、世界の塩基編集市場では、プラットフォームセグメントが製品＆サービスで最大のシェアを占めた。塩基編集プラットフォームのような要素は、ガイドRNAの設計から標的細胞への塩基編集剤の送達までのワークフロー全体をカバーするエンドツーエンドのソリューションを提供する。この包括的なアプローチは研究者の実験プロセスを簡素化し、個々のコンポーネントよりもプラットフォームの人気の一因となっている可能性がある。
"2023-2028年の予測期間中、北米地域が引き続き塩基編集市場を支配した"
北米は2022年に世界の塩基編集市場を支配した。北米では、個別化医療、精密治療、遺伝性疾患の治療に重点が置かれているため、高度な遺伝子編集技術に対する需要が高い。その結果、同地域の企業は遺伝子編集技術の導入と投資に積極的である。さらに北米には、分子生物学、遺伝学、バイオテクノロジーの分野で十分な教育を受けた熟練労働力がいる。有能な労働力の存在は、この地域が先進的なゲノム編集技術の開発と応用をリードする能力に貢献している。こうした要因が北米のゲノム編集市場の成長に寄与している。
本レポートのために実施した一次インタビューは以下のように分類できる：

- 回答者別供給側70％、需要側30
- 役職別管理職：45％、CXOおよび取締役：30％、経営幹部：25
- 地域別北米40％、欧州25％、アジア太平洋地域20％、中南米10％、中東・アフリカ5
レポート掲載企業一覧
- ダナハー社（米国）
- メルクKGaA（ドイツ）
- レヴィティ（米国）
- マラバイ・ライフサイエンシズ（米国）
- GenScript（中国）
- ビーム・セラピューティクス（米）
- インテリア・セラピューティクス（米）
- セレクティス（仏）
- エレベートバイオ（米）
- クリエイティブ・バイオジーン（米）
- バイオパレット（日本）
- アドジーン（米）
- シンセゴ（米）
- エディジーン（中国）
- シェイプTX（米）
- ペアワイズ（米）
- プロQRセラピューティクス（オランダ）
- QIバイオデザイン（中国）
- KromaTiD社（米国）
- GenKOre.（韓国）。
調査範囲
この調査レポートは、塩基編集市場を製品＆サービス（サービス（gRNA設計、細胞株工学、その他のサービス）製品（プラットフォーム、キット＆試薬、プラスミド、塩基編集ライブラリ）別、対象塩基別（シトシン塩基編集、アデニン塩基編集）、タイプ別（DNA塩基編集、RNA塩基編集）、用途別（創薬＆開発、農業、獣医）、エンドユーザー別（製薬＆バイオテクノロジー企業、学術＆研究機関、受託研究機関）に分類しています。
本レポートでは、塩基編集市場の成長を形成する促進要因、動向、課題、機会などの主要な影響要因に関する詳細情報を網羅しています。主要な業界プレイヤーを包括的に分析し、事業概要、製品、主要戦略、提携、パートナーシップ、契約などに関する洞察を提供しています。また、ベースエディティング市場における新製品発表、合併、買収などの最近の動向についても取り上げています。
レポート購入の主な利点
本レポートは、ベースエディティング市場全体とそのサブセグメントにおける収益数の最も近い近似値を提供することで、市場リーダー/新規参入者を支援します。また、利害関係者が競争状況をよりよく理解し、自社のビジネスをよりよく位置づけ、適切な市場参入戦略を立てるための洞察を深めるのにも役立ちます。本レポートは、関係者が市場の鼓動を理解し、主要な市場促進要因、阻害要因、機会、および課題に関する情報を提供することを可能にします。
本レポートは、以下のポイントに関する洞察を提供します：
- 市場の成長に影響を与える主要な促進要因（政府資金の増加とゲノミクス研究の成長、医薬品におけるゲノミクスの応用の増加、希少疾患の有病率の上昇、塩基編集による精度の向上とオフターゲット効果の低減）、阻害要因（倫理と安全性の懸念）、機会（遺伝子治療のパイプラインの増加と規制当局の承認）、課題（オフターゲット効果に関連する課題）の分析。
- 製品開発/イノベーション：塩基編集市場で新たに発売された製品に関する詳細な洞察
- 市場開発：有利な市場に関する包括的な情報 - 当レポートでは様々な地域の市場を分析しています。
- 市場の多様化：塩基編集市場における新製品、未開拓地域、最近の開発、投資に関する詳細な情報
- 競合の評価Danaher Corporation（米国）、Merck KGaA（ドイツ）、Revvity（米国）、Maravai LifeSciences（米国）、GenScript（中国）、Beam Therapeutics（米国）、Intellia Therapeutics, Inc.（米国）、Cellectis（フランス）、ElevateBio（米国）、Creative Biogene（米国）、Bio Palette Co、Ltd.（日本）、Addgene社（米国）、Synthego社（米国）、EdiGene社（中国）、Shape TX社（米国）、Pairwise社（米国）、ProQR Therapeutics社（オランダ）、QI-Biodesign社（中国）、KromaTiD社（米国）、GenKOre.社（韓国）などが市場に参入している。

ページTOPに戻る

1 INTRODUCTION 39
1.1 STUDY OBJECTIVES 39
1.2 MARKET DEFINITION AND SCOPE 39
1.2.1 INCLUSIONS AND EXCLUSIONS 40
1.2.2 MARKETS COVERED 40
1.2.3 YEARS CONSIDERED 41
1.3 CURRENCY 41
1.4 STAKEHOLDERS 41
1.5 LIMITATIONS 42
1.6 RECESSION IMPACT 42
2 RESEARCH METHODOLOGY 43
2.1 RESEARCH DATA 43
FIGURE 1 RESEARCH DESIGN 43
2.1.1 SECONDARY DATA 44
2.1.2 PRIMARY DATA 44
FIGURE 2 BREAKDOWN OF PRIMARIES: BASE EDITING MARKET 45
2.2 MARKET ESTIMATION METHODOLOGY 45
FIGURE 3 BASE EDITING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022 45
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022 46
2.2.1 INSIGHTS FROM PRIMARY EXPERTS 47
FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 47
2.3 MARKET GROWTH RATE PROJECTIONS 48
FIGURE 6 BASE EDITING MARKET (SUPPLY-SIDE): CAGR PROJECTIONS 49
FIGURE 7 BASE EDITING MARKET (DEMAND-SIDE): CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 49
2.3.1 DATA TRIANGULATION 50
FIGURE 8 DATA TRIANGULATION METHODOLOGY 50
2.4 RESEARCH ASSUMPTIONS 51
2.5 RISK ANALYSIS 51
2.6 IMPACT OF RECESSION ON BASE EDITING MARKET 51
TABLE 1 US: HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 52
TABLE 2 US: HEALTH EXPENDITURE, 2023–2030 (USD MILLION) 52
3 EXECUTIVE SUMMARY 53
FIGURE 9 BASE EDITING PRODUCTS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 53
FIGURE 10 BASE EDITING MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 54
FIGURE 11 BASE EDITING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 54
FIGURE 12 BASE EDITING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 55
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF BASE EDITING MARKET 56
4 PREMIUM INSIGHTS 57
4.1 BASE EDITING MARKET OVERVIEW 57
FIGURE 14 GROWING FOCUS ON GENOMIC STUDIES TO DRIVE MARKET 57
4.2 ASIA PACIFIC: BASE EDITING MARKET, BY APPLICATION AND COUNTRY (2022) 58
FIGURE 15 DRUG DISCOVERY & DEVELOPMENT SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 58
4.3 BASE EDITING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 59
FIGURE 16 SOUTH KOREA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 59
4.4 BASE EDITING MARKET SHARE, BY END USER, 2023 59
FIGURE 17 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT TO DOMINATE MARKET IN 2023 59
5 MARKET OVERVIEW 60
5.1 INTRODUCTION 60
5.2 MARKET DYNAMICS 60
FIGURE 18 BASE EDITING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 60
TABLE 3 IMPACT ANALYSIS: BASE EDITING MARKET 61
5.2.1 DRIVERS 61
5.2.1.1 Increasing government funding and growing focus on genomic studies 61
5.2.1.2 Increased applications of genomic research in pharmaceuticals 63
5.2.1.3 Rising prevalence of rare diseases 63
5.2.1.4 Increased precision, better safety, and reduced off-target effects 64
5.2.2 RESTRAINTS 64
5.2.2.1 Ethical and safety concerns 64
5.2.3 OPPORTUNITIES 65
5.2.3.1 Increasing pipeline of gene therapy products and regulatory approvals 65
FIGURE 19 ONGOING CLINICAL TRIALS FOR GENE THERAPY BY PHASE (TILL Q2 2023) 66
5.2.4 CHALLENGES 66
5.2.4.1 Lack of expertise to develop base editors with higher specificity 66
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 66
FIGURE 20 REVENUE SHIFT AND NEW POCKETS FOR BASE EDITING PRODUCT PROVIDERS 67
5.4 PRICING ANALYSIS 67
TABLE 4 AVERAGE SELLING PRICE OF KEY PRODUCTS IN MARKET 67
TABLE 5 COST OF PRODUCT, BY REGION 68
5.5 VALUE CHAIN ANALYSIS 68
FIGURE 21 VALUE CHAIN ANALYSIS: RAW MATERIAL AND MANUFACTURING PHASES ADD MAXIMUM VALUE 68
5.6 SUPPLY CHAIN ANALYSIS 69
FIGURE 22 BASE EDITING MARKET: SUPPLY CHAIN ANALYSIS 70
5.7 ECOSYSTEM MARKET MAP 70
FIGURE 23 BASE EDITING MARKET: ECOSYSTEM MARKET MAP 70
TABLE 6 BASE EDITING MARKET: ROLE IN ECOSYSTEM 71
5.8 TECHNOLOGY ANALYSIS 72
TABLE 7 BASE EDITING MARKET: TECHNOLOGY ANALYSIS 72
5.9 PATENT ANALYSIS 73
FIGURE 24 PATENT APPLICATIONS FOR BASE EDITING MARKET, JANUARY 2013–OCTOBER 2023 73
TABLE 8 INDICATIVE LIST OF PATENTS IN BASE EDITING MARKET 74
5.10 KEY CONFERENCES & EVENTS 75
TABLE 9 DETAILED LIST OF KEY CONFERENCES & EVENTS, 2023–2024 75
5.11 REGULATORY SCENARIO 76
5.11.1 REGULATORY ANALYSIS 76
5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
TABLE 11 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
TABLE 12 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 13 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
TABLE 14 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
5.12 PORTER’S FIVE FORCES ANALYSIS 80
TABLE 15 BASE EDITING MARKET: PORTER’S FIVE FORCES ANALYSIS 80
5.12.1 THREAT OF NEW ENTRANTS 80
5.12.2 THREAT OF SUBSTITUTES 81
5.12.3 BARGAINING POWER OF SUPPLIERS 81
5.12.4 BARGAINING POWER OF BUYERS 81
5.12.5 INTENSITY OF COMPETITIVE RIVALRY 81
5.13 KEY STAKEHOLDERS & BUYING CRITERIA 82
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 82
FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 82
5.13.1.1 Role of stakeholders in buying process 82
5.13.2 BUYING CRITERIA 83
FIGURE 26 KEY BUYING CRITERIA FOR END USERS 83

6 BASE EDITING MARKET, BY PRODUCT & SERVICE 85
6.1 INTRODUCTION 86
TABLE 16 BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 86
6.2 PRODUCTS 86
TABLE 1 BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 86
TABLE 2 BASE EDITING PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION) 87
TABLE 3 NORTH AMERICA: BASE EDITING PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 87
TABLE 4 EUROPE: BASE EDITING PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 87
TABLE 5 ASIA PACIFIC: BASE EDITING PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 6 LATIN AMERICA: BASE EDITING PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 7 MIDDLE EAST & AFRICA: BASE EDITING PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION) 88
6.2.1 PLATFORMS 89
6.2.1.1 Repetitive purchase of technology platforms to support market growth 89
TABLE 8 PLATFORMS MARKET, BY REGION, 2021–2028 (USD MILLION) 89
TABLE 9 NORTH AMERICA: PLATFORMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 90
TABLE 10 EUROPE: PLATFORMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 90
TABLE 11 ASIA PACIFIC: PLATFORMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 90
TABLE 12 LATIN AMERICA: PLATFORMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 91
TABLE 13 MIDDLE EAST & AFRICA: PLATFORMS MARKET, BY REGION, 2021–2028 (USD MILLION) 91
6.2.2 KITS & REAGENTS 91
6.2.2.1 Increasing prevalence of rare diseases to drive growth 91
TABLE 14 KITS & REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 92
TABLE 15 NORTH AMERICA: KITS & REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
TABLE 16 EUROPE: KITS & REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
TABLE 17 ASIA PACIFIC: KITS & REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 18 LATIN AMERICA: KITS & REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 19 MIDDLE EAST & AFRICA: KITS & REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 93
6.2.3 PLASMIDS 94
6.2.3.1 Plasmid-encoded base editors crucial tool for in vivo base editing 94
TABLE 20 PLASMIDS MARKET, BY REGION, 2021–2028 (USD MILLION) 94
TABLE 21 NORTH AMERICA: PLASMIDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 22 EUROPE: PLASMIDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 23 ASIA PACIFIC: PLASMIDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 24 LATIN AMERICA: PLASMIDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 96
TABLE 25 MIDDLE EAST & AFRICA: PLASMIDS MARKET, BY REGION, 2021–2028 (USD MILLION) 96
6.2.4 BASE EDITING LIBRARIES 96
6.2.4.1 Increased application of base editing in therapeutics to drive growth 96
TABLE 26 BASE EDITING LIBRARIES MARKET, BY REGION, 2021–2028 (USD MILLION) 97
TABLE 27 NORTH AMERICA: BASE EDITING LIBRARIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 97
TABLE 28 EUROPE: BASE EDITING LIBRARIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 97
TABLE 29 ASIA PACIFIC: BASE EDITING LIBRARIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 98
TABLE 30 LATIN AMERICA: BASE EDITING LIBRARIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 98
TABLE 31 MIDDLE EAST & AFRICA: BASE EDITING LIBRARIES MARKET, BY REGION, 2021–2028 (USD MILLION) 98
6.3 SERVICES 99
TABLE 32 BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 99
TABLE 33 BASE EDITING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 99
TABLE 34 NORTH AMERICA: BASE EDITING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 35 EUROPE: BASE EDITING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 100
TABLE 36 ASIA PACIFIC: BASE EDITING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 100
TABLE 37 LATIN AMERICA: BASE EDITING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 38 MIDDLE EAST & AFRICA: BASE EDITING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 101
6.3.1 GRNA DESIGNING 101
6.3.1.1 Wide application of gene editing/genome engineering services to drive growth 101
TABLE 39 GRNA DESIGNING MARKET, BY REGION, 2021–2028 (USD MILLION) 102
TABLE 40 NORTH AMERICA: GRNA DESIGNING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 41 EUROPE: GRNA DESIGNING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 42 ASIA PACIFIC: GRNA DESIGNING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 43 LATIN AMERICA: GRNA DESIGNING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 44 MIDDLE EAST & AFRICA: GRNA DESIGNING MARKET, BY REGION, 2021–2028 (USD MILLION) 103
6.3.2 CELL LINE ENGINEERING 104
6.3.2.1 Cell line engineering tools valuable in drug discovery and therapeutic screening 104
TABLE 45 CELL LINE ENGINEERING MARKET, BY REGION, 2021–2028 (USD MILLION) 104
TABLE 46 NORTH AMERICA: CELL LINE ENGINEERING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 47 EUROPE: CELL LINE ENGINEERING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 48 ASIA PACIFIC: CELL LINE ENGINEERING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 49 LATIN AMERICA: CELL LINE ENGINEERING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 50 MIDDLE EAST & AFRICA: CELL LINE ENGINEERING MARKET, BY REGION, 2021–2028 (USD MILLION) 106
6.3.3 OTHER SERVICES 106
TABLE 51 OTHER SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 107
TABLE 52 NORTH AMERICA: OTHER SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 53 EUROPE: OTHER SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 54 ASIA PACIFIC: OTHER SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 108
TABLE 55 LATIN AMERICA: OTHER SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 108
TABLE 56 MIDDLE EAST & AFRICA: OTHER SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 108
7 BASE EDITING MARKET, BY TYPE 109
7.1 INTRODUCTION 110
TABLE 57 BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION) 110
7.2 DNA BASE EDITING 110
7.2.1 CONTINUOUS RESEARCH AND IMPROVEMENTS IN BASE EDITING TECHNOLOGY TO DRIVE MARKET 110
TABLE 58 DNA BASE EDITING MARKET, BY REGION, 2021–2028 (USD MILLION) 111
TABLE 59 NORTH AMERICA: DNA BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 60 EUROPE: DNA BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 61 ASIA PACIFIC: DNA BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 62 LATIN AMERICA: DNA BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 63 MIDDLE EAST & AFRICA: DNA BASE EDITING MARKET, BY REGION, 2021–2028 (USD MILLION) 112
7.3 RNA BASE EDITING 113
7.3.1 REVERSIBLE TRANSITION WITH RNA BASE EDITING TO SUPPORT MARKET GROWTH 113
TABLE 64 RNA BASE EDITING MARKET, BY REGION, 2021–2028 (USD MILLION) 113
TABLE 65 NORTH AMERICA: RNA BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 66 EUROPE: RNA BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 67 ASIA PACIFIC: RNA BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 68 LATIN AMERICA: RNA BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 69 MIDDLE EAST & AFRICA: RNA BASE EDITING MARKET, BY REGION, 2021–2028 (USD MILLION) 115
8 BASE EDITING MARKET, BY TARGETED BASE 116
8.1 INTRODUCTION 117
TABLE 70 BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION) 117
8.2 CYTOSINE BASE EDITING 117
8.2.1 INCREASED USE IN BIOTECHNOLOGY AND AGRICULTURE TO DRIVE MARKET 117
TABLE 71 CYTOSINE BASE EDITING MARKET, BY REGION, 2021–2028 (USD MILLION) 118
TABLE 72 NORTH AMERICA: CYTOSINE BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 73 EUROPE: CYTOSINE BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 74 ASIA PACIFIC: CYTOSINE BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 119
TABLE 75 LATIN AMERICA: CYTOSINE BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 119
TABLE 76 MIDDLE EAST & AFRICA: CYTOSINE BASE EDITING MARKET, BY REGION, 2021–2028 (USD MILLION) 119
8.3 ADENINE BASE EDITING 120
8.3.1 ONGOING RESEARCH FOR INCREASING EFFICIENCY AND APPLICATIONS TO DRIVE MARKET 120
TABLE 77 ADENINE BASE EDITING MARKET, BY REGION, 2021–2028 (USD MILLION) 120
TABLE 78 NORTH AMERICA: ADENINE BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 79 EUROPE: ADENINE BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 80 ASIA PACIFIC: ADENINE BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 81 LATIN AMERICA: ADENINE BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 82 MIDDLE EAST & AFRICA: ADENINE BASE EDITING MARKET, BY REGION, 2021–2028 (USD MILLION) 122
9 BASE EDITING MARKET, BY APPLICATION 123
9.1 INTRODUCTION 124
TABLE 83 BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 124
9.2 DRUG DISCOVERY & DEVELOPMENT 124
9.2.1 GROWING RESEARCH IN DRUG DISCOVERY TO DRIVE MARKET 124
TABLE 84 BASE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2021–2028 (USD MILLION) 125
TABLE 85 NORTH AMERICA: BASE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 86 EUROPE: BASE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 87 ASIA PACIFIC: BASE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 88 LATIN AMERICA: BASE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 89 MIDDLE EAST & AFRICA: BASE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2021–2028 (USD MILLION) 126
9.3 AGRICULTURE 127
9.3.1 INCREASING FUNDING FROM GOVERNMENT BODIES AND PRIVATE ORGANIZATIONS TO DRIVE MARKET 127
TABLE 90 BASE EDITING MARKET FOR AGRICULTURE, BY REGION, 2021–2028 (USD MILLION) 127
TABLE 91 NORTH AMERICA: BASE EDITING MARKET FOR AGRICULTURE, BY COUNTRY, 2021–2028 (USD MILLION) 128
TABLE 92 EUROPE: BASE EDITING MARKET FOR AGRICULTURE, BY COUNTRY, 2021–2028 (USD MILLION) 128
TABLE 93 ASIA PACIFIC: BASE EDITING MARKET FOR AGRICULTURE, BY COUNTRY, 2021–2028 (USD MILLION) 128
TABLE 94 LATIN AMERICA: BASE EDITING MARKET FOR AGRICULTURE, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 95 MIDDLE EAST & AFRICA: BASE EDITING MARKET FOR AGRICULTURE, BY REGION, 2021–2028 (USD MILLION) 129
9.4 VETERINARY 129
9.4.1 INCREASING USE OF ANIMAL SIMULATION MODELS IN RESEARCH TO DRIVE MARKET 129
TABLE 96 BASE EDITING MARKET FOR VETERINARY, BY REGION, 2021–2028 (USD MILLION) 130
TABLE 97 NORTH AMERICA: BASE EDITING MARKET FOR VETERINARY, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 98 EUROPE: BASE EDITING MARKET FOR VETERINARY, BY COUNTRY, 2021–2028 (USD MILLION) 131
TABLE 99 ASIA PACIFIC: BASE EDITING MARKET FOR VETERINARY, BY COUNTRY, 2021–2028 (USD MILLION) 131
TABLE 100 LATIN AMERICA: BASE EDITING MARKET FOR VETERINARY, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 101 MIDDLE EAST & AFRICA: BASE EDITING MARKET FOR VETERINARY, BY REGION, 2021–2028 (USD MILLION) 132

10 BASE EDITING MARKET, BY END USER 133
10.1 INTRODUCTION 134
TABLE 102 BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 134
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 134
10.2.1 INCREASED USE OF CRISPR-BASED TECHNOLOGIES TO DRIVE MARKET 134
TABLE 103 BASE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 135
TABLE 104 NORTH AMERICA: BASE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 105 EUROPE: BASE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 106 ASIA PACIFIC: BASE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 136
TABLE 107 LATIN AMERICA: BASE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 136
TABLE 108 MIDDLE EAST & AFRICA: BASE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 136
10.3 ACADEMIC & RESEARCH INSTITUTES 137
10.3.1 GROWING FOCUS ON LIFE SCIENCE RESEARCH TO SUPPORT MARKET GROWTH 137
TABLE 109 BASE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 137
TABLE 110 NORTH AMERICA: BASE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 138
TABLE 111 EUROPE: BASE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 138
TABLE 112 ASIA PACIFIC: BASE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 138
TABLE 113 LATIN AMERICA: BASE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 114 MIDDLE EAST & AFRICA: BASE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 139
10.4 CONTRACT RESEARCH ORGANIZATIONS 139
10.4.1 GROWING ADOPTION OF STEM CELL THERAPY AND ONGOING CLINICAL RESEARCH TO PROPEL MARKET 139
TABLE 115 BASE EDITING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021–2028 (USD MILLION) 140
TABLE 116 NORTH AMERICA: BASE EDITING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 140
TABLE 117 EUROPE: BASE EDITING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 140
TABLE 118 ASIA PACIFIC: BASE EDITING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 119 LATIN AMERICA: BASE EDITING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 120 MIDDLE EAST & AFRICA: BASE EDITING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021–2028 (USD MILLION) 141
11 BASE EDITING MARKET, BY REGION 142
11.1 INTRODUCTION 143
TABLE 121 BASE EDITING MARKET, BY REGION, 2021–2028 (USD MILLION) 143
11.2 NORTH AMERICA 143
FIGURE 27 NORTH AMERICA: BASE EDITING MARKET SNAPSHOT 144
TABLE 122 NORTH AMERICA: BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 123 NORTH AMERICA: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 145
TABLE 124 NORTH AMERICA: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 145
TABLE 125 NORTH AMERICA: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 145
TABLE 126 NORTH AMERICA: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION) 146
TABLE 127 NORTH AMERICA: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION) 146
TABLE 128 NORTH AMERICA: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 146
TABLE 129 NORTH AMERICA: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 147
11.2.1 US 147
11.2.1.1 Robust investment in genomics field to drive market 147
TABLE 130 US: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 148
TABLE 131 US: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 148
TABLE 132 US: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 133 US: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 134 US: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION) 149
TABLE 135 US: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 150
TABLE 136 US: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 150
11.2.2 CANADA 150
11.2.2.1 Availability of government funding for genomics research to support market growth 150
TABLE 137 CANADA: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 151
TABLE 138 CANADA: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 151
TABLE 139 CANADA: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 152
TABLE 140 CANADA: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION) 152
TABLE 141 CANADA: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION) 152
TABLE 142 CANADA: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 153
TABLE 143 CANADA: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 153
11.2.3 RECESSION IMPACT ON NORTH AMERICAN BASE EDITING MARKET 153
11.3 EUROPE 154
TABLE 144 EUROPE: BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 145 EUROPE: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 154
TABLE 146 EUROPE: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 155
TABLE 147 EUROPE: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 155
TABLE 148 EUROPE: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION) 155
TABLE 149 EUROPE: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION) 156
TABLE 150 EUROPE: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 156
TABLE 151 EUROPE: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 156
11.3.1 GERMANY 157
11.3.1.1 Strong academic base and rising awareness to drive growth 157
TABLE 152 GERMANY: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 157
TABLE 153 GERMANY: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 157
TABLE 154 GERMANY: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 155 GERMANY: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 156 GERMANY: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION) 158
TABLE 157 GERMANY: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 159
TABLE 158 GERMANY: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 159
11.3.2 UK 159
11.3.2.1 Largest market for genome engineering in Europe 159
TABLE 159 UK: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 160
TABLE 160 UK: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 161
TABLE 161 UK: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 161
TABLE 162 UK: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION) 161
TABLE 163 UK: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION) 162
TABLE 164 UK: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 162
TABLE 165 UK: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 162
11.3.3 FRANCE 163
11.3.3.1 Government funding for genomics to support market growth 163
TABLE 166 FRANCE: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 163
TABLE 167 FRANCE: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 168 FRANCE: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 169 FRANCE: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 170 FRANCE: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION) 165
TABLE 171 FRANCE: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 165
TABLE 172 FRANCE: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 165
11.3.4 ITALY 166
11.3.4.1 Increasing number of workshops and conferences to propel market growth 166
TABLE 173 ITALY: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 166
TABLE 174 ITALY: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 175 ITALY: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 176 ITALY: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 177 ITALY: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION) 168
TABLE 178 ITALY: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 168
TABLE 179 ITALY: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 168
11.3.5 SPAIN 169
11.3.5.1 Increased focus on personalized medicines to boost market growth 169
TABLE 180 SPAIN: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 169
TABLE 181 SPAIN: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 169
TABLE 182 SPAIN: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 183 SPAIN: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 184 SPAIN: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION) 170
TABLE 185 SPAIN: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 171
TABLE 186 SPAIN: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 171
11.3.6 REST OF EUROPE 171
TABLE 187 REST OF EUROPE: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 172
TABLE 188 REST OF EUROPE: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 189 REST OF EUROPE: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 173
TABLE 190 REST OF EUROPE: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION) 173
TABLE 191 REST OF EUROPE: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION) 173
TABLE 192 REST OF EUROPE: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 174
TABLE 193 REST OF EUROPE: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 174
11.3.7 RECESSION IMPACT ON EUROPEAN BASE EDITING MARKET 174
11.4 ASIA PACIFIC 175
FIGURE 28 ASIA PACIFIC: BASE EDITING MARKET SNAPSHOT 176
TABLE 194 ASIA PACIFIC: BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 177
TABLE 195 ASIA PACIFIC: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 177
TABLE 196 ASIA PACIFIC: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 197 ASIA PACIFIC: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 178
TABLE 198 ASIA PACIFIC: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION) 178
TABLE 199 ASIA PACIFIC: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION) 178
TABLE 200 ASIA PACIFIC: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 179
TABLE 201 ASIA PACIFIC: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 179
11.4.1 CHINA 179
11.4.1.1 Government support for genomics research to favor market growth 179
TABLE 202 CHINA: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 180
TABLE 203 CHINA: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 204 CHINA: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 205 CHINA: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 206 CHINA: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION) 181
TABLE 207 CHINA: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 181
TABLE 208 CHINA: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 182
11.4.2 JAPAN 182
11.4.2.1 Increased focus on cancer research to propel market 182
TABLE 209 JAPAN: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 183
TABLE 210 JAPAN: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 211 JAPAN: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 212 JAPAN: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION) 184
TABLE 213 JAPAN: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION) 184
TABLE 214 JAPAN: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 184
TABLE 215 JAPAN: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 185
11.4.3 INDIA 185
11.4.3.1 Rising number of research activities to support market growth 185
TABLE 216 INDIA: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 186
TABLE 217 INDIA: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 186
TABLE 218 INDIA: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 186
TABLE 219 INDIA: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION) 187
TABLE 220 INDIA: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION) 187
TABLE 221 INDIA: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 187
TABLE 222 INDIA: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 188
11.4.4 SOUTH KOREA 188
11.4.4.1 Increasing focus on gene editing research and applications to drive market 188
TABLE 223 SOUTH KOREA: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 189
TABLE 224 SOUTH KOREA: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 189
TABLE 225 SOUTH KOREA: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 189
TABLE 226 SOUTH KOREA: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION) 190
TABLE 227 SOUTH KOREA: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION) 190
TABLE 228 SOUTH KOREA: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 190
TABLE 229 SOUTH KOREA: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 191
11.4.5 REST OF ASIA PACIFIC 191
TABLE 230 REST OF ASIA PACIFIC: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 192
TABLE 231 REST OF ASIA PACIFIC: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 192
TABLE 232 REST OF ASIA PACIFIC: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 192
TABLE 233 REST OF ASIA PACIFIC: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION) 193
TABLE 234 REST OF ASIA PACIFIC: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION) 193
TABLE 235 REST OF ASIA PACIFIC: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 193
TABLE 236 REST OF ASIA PACIFIC: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 194
11.4.6 RECESSION IMPACT ON ASIA PACIFIC BASE EDITING MARKET 194

ページTOPに戻る

Table of Contents

Summary

The Base editing market is projected to reach USD 549 million by 2028 from an estimated USD 270 million in 2023, at a CAGR of 15.2% during the forecast period. The growth of this market can be attributed to the growing demand for novel genetic therapies and personalized medicine, coupled with the development of newly engineered molecules. That is expected to treat rare genetic disorders and increase the yield of genetically modified crops, propelling the growth of the overall market. The increasing recognition of the role of genetic mutations in various diseases has fueled the demand for precise gene editing technologies. Base editing's ability to correct disease-causing mutations contributes to its relevance in addressing genetic disorders.

“The platform segment accounted for the largest share by product & services in 2022.”
In 2022, the platform segment accounted for the largest share of product & service in the global base editing market. The factors like base editing platforms offer end-to-end solutions that cover the entire workflow from designing guide RNAs to delivering base editors into target cells. This comprehensive approach simplifies the experimentation process for researchers and may contribute to the popularity of platforms over individual components.
“The North America region continued to dominate the base editing market during the forecast period of 2023-2028.”
North America dominated the global base editing market in 2022. The demand for advanced gene editing technologies is high in North America due to the region's focus on personalized medicine, precision therapeutics, and the treatment of genetic disorders. As a result, companies in the region are more inclined to adopt and invest in base editing technologies. Moreover, North America has a well-educated and skilled workforce in the fields of molecular biology, genetics, and biotechnology. The availability of a talented workforce contributes to the region's ability to lead in the development and application of advanced genomic editing technologies. These factors are contributing to the growth of the North American base editing market.
The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 70% and Demand Side 30%
• By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25%
• By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10% and Middle East & Africa- 5%
List of Companies Profiled in the Report:
• Danaher Corporation (US)
• Merck KGaA (Germany)
• Revvity (US)
• Maravai LifeSciences (US)
• GenScript (China)
• Beam Therapeutics (US)
• Intellia Therapeutics, Inc. (US)
• Cellectis (France)
• ElevateBio (US)
• Creative Biogene (US)
• Bio Palette Co., Ltd (Japan)
• Addgene (US)
• Synthego (US)
• EdiGene, Inc. (China)
• Shape TX (US)
• Pairwise (US)
• ProQR Therapeutics (Netherlands)
• QI-Biodesign (China)
• KromaTiD, Inc. (US)
• GenKOre. (South Korea).
Research Coverage:
This research report categorizes the base editing market by product & service (service (gRNA design, cell line engineering, and other services) product (platforms, kits & reagents, plasmids, and base editing libraries), by targeted base (cytosine base editor, adenine base editor), by type (DNA base editing, RNA base editing), by application (drug discovery & development, agriculture, and veterinary), by end user (pharmaceutical & biotechnological companies, academic & research institutes, and contract research organizations).
The report's scope encompasses detailed information regarding major influencing factors such as drivers, trends, challenges, and opportunities shaping the growth of the base editing market. A comprehensive analysis of key industry players has been conducted to offer insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. The report also covers recent developments, including new product launches, mergers, and acquisitions, in the base editing market.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall base editing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
• Analysis of key drivers (the rising government funding and growth of genomics studies, increased applications of genomics in pharmaceuticals, rising prevalence of rare diseases, and increased precision & reduced off-target effects with base editing), restraints (ethical & safety concerns), opportunities (Increasing pipeline of gene therapy & regulatory approvals), and challenges (Challenges associated with off-target effects) influencing the growth of the market.
• Product Development/Innovation: Detailed insights on newly launched products in the base editing market
• Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the base editing market
• Competitive Assessment: Danaher Corporation (US), Merck KGaA (Germany), Revvity (US), Maravai LifeSciences (US), GenScript (China), Beam Therapeutics (US), Intellia Therapeutics, Inc. (US), Cellectis (France), ElevateBio (US), Creative Biogene (US), Bio Palette Co., Ltd (Japan), Addgene (US), Synthego (US), EdiGene, Inc. (China), Shape TX (US), Pairwise (US), ProQR Therapeutics (Netherlands), QI-Biodesign (China), KromaTiD, Inc. (US), GenKOre. (South Korea) and among others in the market.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（バイオ薬物）の最新刊レポート

MarketsandMarkets社のBiotechnology分野での最新刊レポート

本レポートと同じKEY WORD（application drug）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（バイオ薬物）の最新刊レポート

MarketsandMarkets社のBiotechnology分野での最新刊レポート

本レポートと同じKEY WORD（application drug）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?